Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BASA Scale Pilot Validation Study
NCT01062269Phase 4Completed
- Sponsor
- Louisville Metabolic and Atherosclerosis Research Center
- Start
- Jan 2010
- Primary completion
- Feb 2010
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of cholestyramine in hypercholesterolemia (3 arms), sponsored by Louisville Metabolic and Atherosclerosis Research Center. Primary endpoint: Patient Acceptability of Orange-flavored Generic Questran (Cholestyramine) vs. Tang Via 2 Versions of a Bile Acid Sequestrant Acceptability (BASA) Scale at 1 Day. Started Jan 2010; status: completed.
02
Drugs
cholestyramine
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT01062269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01062269.